Mouse Anti-MOXD1 Recombinant Antibody (CBFYM-0708) (CBMAB-M0850-FY)

Lai, Y., Dong, H., Xu, P., Wang, J., Feng, W., Zhao, Z., & Sha, L. (2024). RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer. BMC gastroenterology, 24(1), 1-14.

Pan, T., Zhao, Z., Lu, J., Wen, H., Zhang, J., Xu, Y., ... & Jin, X. (2024). Fenofibrate inhibits MOXD1 and PDZK1IP1 expression and improves lipid deposition and inflammation in mice with alcoholic fatty liver. Life Sciences, 336, 122321.

Fredlund, E., Andersson, S., Hilgert, E., Álvarez-Hernán, G., Monferrer, E., Karakaya, S., ... & Mohlin, S. (2023). MOXD1 is a gate-keeper of organ homeostasis and functions as a tumor-suppressor in neuroblastoma. bioRxiv, 2023-01.

Fredlund, E., Andersson, S., Ferreira, M., & Mohlin, S. (2023). Trunk neural crest gene MOXD1 affects embryonic development. bioRxiv, 2023-08.

Shi, P., Xu, J., Xia, F., Wang, Y., Ren, J., Liang, P., & Cui, H. (2022). MOXD1 knockdown suppresses the proliferation and tumor growth of glioblastoma cells via ER stress-inducing apoptosis. Cell Death Discovery, 8(1), 174.

Wang, W., Hua, S., Li, J., Zhao, J., Zhang, Y., Jiang, J., & Han, B. (2022). Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature. Frontiers in Oncology, 12, 1081091.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Isotype control